Horizon Discovery and Fulcrum Therapeutics Form Collaboration for Novel CRISPR-Based Target Discovery in Genetic Diseases
Exploration into the development of next-generation therapies
Exploration into the development of next-generation therapies
The research will be carried out at Plasticell and in the laboratory of Dr. Eva Szegezdi at the Apoptosis Research Centre, NUI Galway
New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture
Cellca’s cell line and upstream process development services now integrated
The all-new rapifleX™ extends MALDI leadership in protein characterization, biologics development and QC, as well as in Mass Spectrometry Imaging (MSI)
Apply now to trial the new Lonza CytoSMART™
New application notes, videos and technologies
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
SelectScience® brought a grand piano to the Pittcon show floor for the first time ever
Mr. Alpert is to provide support to UVM management on policy, budgets and strategic planning
SelectScience® spoke to SLAS2016 Special Interest Group Chair, Dr Raymond Price
The SeqCap EZ DNA kit allows easy target enrichment, whilst avoiding human error
Good laboratory techniques to protect yourself, your experiments and your working environment
PrimaDiag provide automated library preparation for next-generation sequencing
ibidi extends its existing product range for classic immunofluorescence experiments that use standard coverslip techniques
Irvine Scientific announce the launch of BalanCDR CHO Feed 4
Discover the most exciting new developments in cell biology research this month
Hear from the winner of the Best New Drug Discovery Product of 2015, Thermo Fisher Scientific
Discover the winning product, voted for by scientists worldwide